HomeLarge Type Edition
HOME ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
PubMed
Right arrow PubMed Citation
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 58:M1137-M1144 (2003)
© 2003 The Gerontological Society of America

Does Antidepressant Therapy Improve Cognition in Elderly Depressed Patients?

P. Murali Doraiswamy1, K. Ranga Rama Krishnan1, Thomas Oxman2, Lawrence R. Jenkyn2, David J. Coffey2, Tal Burt3 and Cathryn M. Clary3

1 Departments of Psychiatry and Medicine, Duke University Medical Center, Durham, North Carolina.
2 Dartmouth Medical School, Lebanon, New Hampshire.
3 Pfizer, Inc., New York, New York.

Objectives. To analyze the effects of antidepressants on cognitive functioning in elderly depression.

Methods. Data were pooled for elderly participants with major depression from two double-blind 12-week studies (n = 444) comparing sertraline to fluoxetine and to nortriptyline. A cognitive battery was performed pre-treatment and post-treatment that included the Shopping List Task (SLT), which quantifies short-term and long-term memory storage and retrieval, and the Digit Symbol Substitution Test (DSST), which measures visual tracking, motor performance, and coding.

Results.Older age, male gender, higher systolic blood pressure, and higher illness severity were associated with lower performance on specific cognitive measures at baseline. For the entire group, improved depression and a lower anticholinergic side effect (dry mouth and constipation) severity were associated with statistically significant improvement in the SLT and DSST. The correlations between improvements in depression and improvement in tested cognitive function were highest for sertraline followed by nortriptyline and then fluoxetine.

Conclusions. Acute improvement in depression is associated with cognitive improvement as measured by the SLT and DSST. Prospective studies are warranted to study the effects of potential differences among antidepressant therapies on long-term cognitive outcomes in geriatric depression.




This article has been cited by other articles:


Home page
J Geriatr Psychiatry NeurolHome page
J. O. Brooks and J. C. Hoblyn
Neurocognitive Costs and Benefits of Psychotropic Medications in Older Adults
J Geriatr Psychiatry Neurol, December 1, 2007; 20(4): 199 - 214.
[Abstract] [PDF]


Home page
The Annals of PharmacotherapyHome page
C. L Raehl, C. Bond, T. J Woods, R. A Patry, and R. B Sleeper
Screening Tests for Intended Medication Adherence Among the Elderly
Ann. Pharmacother., May 1, 2006; 40(5): 888 - 893.
[Abstract] [Full Text] [PDF]




HOME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by The Gerontological Society of America.